Your browser doesn't support javascript.
loading
Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970-2009.
Duane, Frances K; Boekel, Naomi B; Jacobse, Judy N; Wang, Zhe; Aleman, Berthe M P; Darby, Sarah C; Schaapveld, Michael; van Leeuwen, Flora E; Baaijens, Margreet H A; Warren, Samantha; Taylor, Carolyn W.
Afiliación
  • Duane FK; St. Luke's Radiation Oncology Network, St. Luke's Hospital, Dublin, Ireland.
  • Boekel NB; School of Medicine, Trinity College Dublin, Ireland.
  • Jacobse JN; Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland.
  • Wang Z; Netherlands Cancer Institute, Epidemiology, Amsterdam, The Netherlands.
  • Aleman BMP; Netherlands Cancer Institute, Epidemiology, Amsterdam, The Netherlands.
  • Darby SC; Nuffield Department of Population Health, University of Oxford, UK.
  • Schaapveld M; Netherlands Cancer Institute, Radiation Oncology, Amsterdam, The Netherlands.
  • van Leeuwen FE; Nuffield Department of Population Health, University of Oxford, UK.
  • Baaijens MHA; Netherlands Cancer Institute, Epidemiology, Amsterdam, The Netherlands.
  • Warren S; Netherlands Cancer Institute, Epidemiology, Amsterdam, The Netherlands.
  • Taylor CW; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
Clin Transl Radiat Oncol ; 36: 132-139, 2022 Sep.
Article en En | MEDLINE | ID: mdl-36034326
Purpose: To describe cardiac exposure from breast cancer radiotherapy regimens used during 1970-2009 for the development of dose-response relationships and to consider the associated radiation-risks using existing dose-response relationships. Material and methods: Radiotherapy charts for 771 women in the Netherlands selected for case control studies of heart disease after breast cancer radiotherapy were used to reconstruct 44 regimens on a typical CT-dataset. Doses were estimated for the whole heart (WH), left ventricle (LV) and cardiac valves. Results: For breast/chest wall radiotherapy average WH doses decreased during 1970-2009. For internal mammary chain (IMC) radiotherapy WH doses were highest during the 1980s and 1990s when direct anterior fields were used and reduced in the 2000s when oblique fields were introduced. Average doses varied substantially for IMC regimens (WH 2-33 Gy, LV < 1-23 Gy). For cardiac valves, at least one valve received >30 Gy from most regimens. Conclusions: Radiation-risks of IHD from breast/chest wall regimens likely reduced during 1970-2009. Direct anterior IMC regimens likely increased the risks of IHD and VHD over this time period but the use of oblique IMC fields from 2003 may have lowered these risks. These data provide a unique opportunity to develop dose-response relationships.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Clin Transl Radiat Oncol Año: 2022 Tipo del documento: Article País de afiliación: Irlanda

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Clin Transl Radiat Oncol Año: 2022 Tipo del documento: Article País de afiliación: Irlanda